Equities

Syncom Formulations (India) Ltd

SYNCOMF:NSI

Syncom Formulations (India) Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)22.71
  • Today's Change0.31 / 1.38%
  • Shares traded11.54m
  • 1 Year change+162.54%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income340266262
Depreciation/depletion474539
Non-Cash items(82)(107)(111)
Cash taxes paid, supplemental816762
Cash interest paid, supplemental453114
Changes in working capital(365)(99)(27)
Total cash from operations(60)105163
INVESTING
Capital expenditures(81)(206)(113)
Other investing and cash flow items, total912(243)(158)
Total cash from investing830(450)(271)
FINANCING
Financing cash flow items(39)(21)(10)
Total cash dividends paid--(28)--
Issuance (retirement) of stock, net--146136
Issuance (retirement) of debt, net(107)254(43)
Total cash from financing(146)35083
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash6255.78(24)
Net cash-begin balance/reserved for future use8.803.0228
Net cash-end balance/reserved for future use6348.803.02
SUPPLEMENTAL INCOME
Depreciation, supplemental474539
Cash interest paid, supplemental453114
Cash taxes paid, supplemental816762
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.